The present work was designed to study H. pylori infection in type 2 DM, its relation to some clinical; metabolic and radiological markers of atherosclerosis and vascular complications in type 2 DM.
Introduction
he chronic hyperglycemia of diabetes is associated with long term damage, dysfunction and failure of various organs especially the eyes, kidneys, nerves, heart and blood vesselsP 1 P . At least 80% of the diabetic patients will die predominantly from the consequences of vascular complicationsP 2 P . Review of epidemiological studies indicates that classic risk factors for atherosclerosis account for majority but not the entirety of the etiology and pathogenesis of the clinical complications of atherosclerosis, including ischemic heart diseases. The inability of traditional risk factors to completely explain the incidence and trends in cardiovascular diseases has resulted in repeated calls for a search for new risk factors. Infections have been placed among these new putative risk factorsP 3 P . Infection with Helicobacter pylori (H. Pylori; gram negative bacteria) has been epidemiologically linked to some extradigestive conditions, including ischemic heart disease, diabetes mellitus and othersP 4 P . Diabetic patients are at risk of cardiovascular and thrombo-occlusive cerebral diseases. There is a possible relationship between H. pylori infection and cardiovascular or cerebrovascular diseasesP 5 P . The finding that infectious agents are responsible for chronic diseases of unknown cause is not new. Chronic H. pylori colonization may be associated with an increased risk for atherosclerosis. The underlying hypothesis is that H. pylori infection has atherogenic capacities by chronic low-grade activation of the haemostasis cascadeP 6 P . The association between H. pylori and acute cerebrovascular disease seems to be due to a higher prevalence of more virulent H. pylori strains in patients with atherosclerotic strokeP 7 P . Chronic H. pylori infection was associated with a higher risk of stroke due to small artery occlusion and a lower risk of cardio embolic stroke. Chronic H. pylori infection still showed an over all association with ischemic stroke after adjustment of major cardiovascular risk factors. These suggest that chronic H. pylori infection may be a triggering factor that increases the risk of acute ischemic strokeP 8 P . The present work was designed to study H. pylori infection in type 2 DM, its relation to some; metabolic and radiological markers of atherosclerosis and vascular complications in type 2 DM. 
Materials and Methods

Results
The age, sex and body mass index of cases were matched with the control ( Table 1 ). H. pylori was higher in type 2 diabetic patients (38.3%) compared to the healthy control (20%), but this difference was statistically non significant (p value = 0.58l) ( Table 1 ). H. pylori infection had no significant relation to the duration of diabetes (p. Value=0.602). The difference in H pylori seropositivity in relation to type of therapy was statistically non significant (p value = 0.335) as shown in Table 2 Comparison between the different groups by using T test * P: mildly statistically significant (P<0.05). ** P: highly statistically significant (P<0.01). CCA: common carotid artery. Table 4 .
H. pylori infection caused significant increase in the level of Fibrinogen, C reactive protein and some inflammatory cytokines as TNF-alpha and IL.1B as depicted in Table 5 . Intima medial thickness of both right and left common carotid arteries were not significantly affected by H. pylori seropositivity ( 
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Positive Negative atherogenic modified lipid profile among patients with type 2 DM. H. pylori infection was associated with significant increase in triglyceride level,. Significant decrease in HDL level and non significant effect on levels of both LDL and total cholesterol. The present study supports Sung and his coworkers (18) who found that H. pylori infection in healthy Korean adults was associated with atherogenic lipid profile(increase in total cholesterol, triglyceride, LDL cholesterol and decrease in HDL cholesterol) but this study had many limitations (subjects included were healthy, young, self selected and of relatively high socioeconomic status). While in the present study patients were type 2 diabetic aged 30-60 years and of relatively lower socioeconomic status. A lot of studies which provided evidences for association between H. pylori infection and atherogenic modified lipid profile were done. A possible association of H. pylori infection and the development of coronary heart disease, thrombo-occlusive cerebral disease, or both, in diabetic patients. The importance of this link is highlighted by the possibility of an effective intervention against H. pylori infection 19 . Eradication of H. pylori was found to be associated with significant decrease in CRP, significant increase in HDL and non significant effect on LDL, neither triglycerides nor total cholesterol among healthy people with H pylori infection 2 . H. pylori infection is associated with cardiovascular risk factors, especially with triglyceride, HDL-cholesterol and apolipoproteins, independently from the presence of peptic ulcer 21 . Association of H. pylori infection with modified atherogenic lipid profile may be due to lipopolysaccharides present in this gram negative bacteria which stimulate the production of many cytokines including tumor necrosis factor alpha(TNF-)which inhibit lipoprotein lipase activity leading to mobilization of lipids from the tissues and elevated serum triglycerides, lowered HDL cholesterol levels 22 . The present study found significant increase in serum levels of TNF-and IL1-B in patients seropositive for H. pylori infection than seronegative ones. The presence of these inflammatory cytokines in the serum in association with H. pylori infection was demonstrated by a lot of studies. H. pylori seropositivity was found to cause increase in serum TNF-in human 23 , 24 irrespective of the type pf strain included. Cag A positive H. pylori infection was found to be significantly associated with increased TNFlevel than Cag A negative one 25 . Serum level of IL-1B was found to be significantly associated with H. pylori infection in human. A good experimental evidence of association between H pylori infection especially with toxigenic strains (Cag A and Vac A positive) with increased plasma levels of TNF-and IL-1B in rats was supplied by Brzozowski 41 . The differences between previous studies and the present one may be due to predominant effect of cardiovascular risk factors in diabetic patients than direct effect of H. pylori infection. Another explanation is the role of toxigenic strains of H. pylori infection (Cag A and Vac A strains) which were proved to be highly related to IHD 42 and atherosclerotic plaque instability 43 . These toxigenic strains were not examined in the present study. Epidemiologic study has suggested possible atherogenic roles for H. pylori. H. pylori infection is associated with arterial stiffness determined by pulse wave velocity in patients with type 2 diabetes mellitus 44 . The importance of this link is highlighted by the possibility of an effective intervention against H. pylori infection. It is concluded that, there is no significant increase in prevalence of H. pylori infection among type 2 diabetic patients. H. pylori infection is not related to age of the patients, their sex, BMI, duration of diabetes nor to the degree of glycaemic control. H. pylori infection has no direct relation to atherosclerosis (IMT) or vascular (micro and macrovascular) complications among type 2 diabetic patients. However, H. pylori infection may increase atherosclerotic plaque formation, plaque instability and incidence of arterial thrombosis among these patients making them more prone to acute ischemic events .These effects are mediated through modification of lipid profile (increase in TG and decrease HDL levels), increase levels of inflammatory cytokines (TNF-alpha and IL-1B) and acute phase reactants (CRP and Fibrinogen). Due to the above mentioned results and conclusion of the present study, many relations need to be clarified in the future studies. Effect of H. pylori on various clinical, chemical, radiological changes in diabetic patients presented with acute complications especially ischemic events needs clarification and studies. The relations especially the direct relation of H. pylori infection to atherosclerotic plaque formation and plaque instability in patients with DM can be studied in the future. Finally, larger number of patients, form of H. pylori infection (acute or chronic) and presence of virulent strains are important aspects which need to be considered as much as possible.
